Annual Short Term Debt
$5.43 M
+$1.92 M+54.81%
31 December 2023
Summary:
Lyra Therapeutics annual short term debt is currently $5.43 million, with the most recent change of +$1.92 million (+54.81%) on 31 December 2023. During the last 3 years, it has risen by +$4.45 million (+451.68%). LYRA annual short term debt is now at all-time high.LYRA Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$4.00 M
-$266.00 K-6.23%
30 September 2024
Summary:
Lyra Therapeutics quarterly short term debt is currently $4.00 million, with the most recent change of -$266.00 thousand (-6.23%) on 30 September 2024. Over the past year, it has increased by +$2.60 million (+185.32%). LYRA quarterly short term debt is now -26.33% below its all-time high of $5.43 million, reached on 31 December 2023.LYRA Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYRA Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +54.8% | +185.3% |
| 3 y3 years | +451.7% | +280.5% |
| 5 y5 years | +100.0% | - |
LYRA Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +451.7% | -26.3% | +512.1% |
| 5 y | 5 years | at high | -26.3% | +512.1% | |
| alltime | all time | at high | -26.3% | +512.1% |
Lyra Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.00 M(-6.2%) |
| June 2024 | - | $4.27 M(-5.2%) |
| Mar 2024 | - | $4.50 M(-17.1%) |
| Dec 2023 | $5.43 M(+54.8%) | $5.43 M(+287.3%) |
| Sept 2023 | - | $1.40 M(-16.9%) |
| June 2023 | - | $1.69 M(-11.2%) |
| Mar 2023 | - | $1.90 M(-45.9%) |
| Dec 2022 | $3.51 M | $3.51 M(+436.7%) |
| Sept 2022 | - | $654.00 K(-29.4%) |
| June 2022 | - | $926.00 K(-15.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $1.10 M(+2.1%) |
| Dec 2021 | $1.07 M(+9.0%) | $1.07 M(+2.1%) |
| Sept 2021 | - | $1.05 M(+2.2%) |
| June 2021 | - | $1.03 M(+2.2%) |
| Mar 2021 | - | $1.01 M(+2.2%) |
| Dec 2020 | $985.00 K(+9.6%) | $985.00 K(+2.2%) |
| Sept 2020 | - | $964.00 K(+2.2%) |
| June 2020 | - | $943.00 K(+2.6%) |
| Mar 2020 | - | $919.00 K(+2.2%) |
| Dec 2019 | $899.00 K(>+9900.0%) | $899.00 K |
| Dec 2018 | $0.00 | - |
FAQ
- What is Lyra Therapeutics annual short term debt?
- What is the all time high annual short term debt for Lyra Therapeutics?
- What is Lyra Therapeutics annual short term debt year-on-year change?
- What is Lyra Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Lyra Therapeutics?
- What is Lyra Therapeutics quarterly short term debt year-on-year change?
What is Lyra Therapeutics annual short term debt?
The current annual short term debt of LYRA is $5.43 M
What is the all time high annual short term debt for Lyra Therapeutics?
Lyra Therapeutics all-time high annual short term debt is $5.43 M
What is Lyra Therapeutics annual short term debt year-on-year change?
Over the past year, LYRA annual short term debt has changed by +$1.92 M (+54.81%)
What is Lyra Therapeutics quarterly short term debt?
The current quarterly short term debt of LYRA is $4.00 M
What is the all time high quarterly short term debt for Lyra Therapeutics?
Lyra Therapeutics all-time high quarterly short term debt is $5.43 M
What is Lyra Therapeutics quarterly short term debt year-on-year change?
Over the past year, LYRA quarterly short term debt has changed by +$2.60 M (+185.32%)